124 related articles for article (PubMed ID: 26021576)
21. Microbiological assay for gatifloxacin in pharmaceutical formulations.
Salgado HR; Lopes CC; Lucchesi MB
J Pharm Biomed Anal; 2006 Feb; 40(2):443-6. PubMed ID: 16139980
[TBL] [Abstract][Full Text] [Related]
22. Determination of roxithromycin in rat lung tissue by liquid chromatography-mass spectrometry.
Wang P; Qi M; Jin X
J Pharm Biomed Anal; 2005 Sep; 39(3-4):618-23. PubMed ID: 15899569
[TBL] [Abstract][Full Text] [Related]
23. Construction of universal quantitative models for determination of roxithromycin and erythromycin ethylsuccinate in tablets from different manufacturers using near infrared reflectance spectroscopy.
Feng YC; Hu CQ
J Pharm Biomed Anal; 2006 May; 41(2):373-84. PubMed ID: 16406447
[TBL] [Abstract][Full Text] [Related]
24. Demethylation metabolism of roxithromycin in humans and rats.
Li XQ; Zhong DF; Huang HH; Wu SD
Acta Pharmacol Sin; 2001 May; 22(5):469-74. PubMed ID: 11743899
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation.
Ram VR; Dave PN; Joshi HS
J Chromatogr Sci; 2012 Sep; 50(8):721-6. PubMed ID: 22641089
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a reversed-phase HPLC method for simultaneous estimation of ambroxol hydrochloride and azithromycin in tablet dosage form.
Shaikh KA; Patil SD; Devkhile AB
J Pharm Biomed Anal; 2008 Dec; 48(5):1481-4. PubMed ID: 18993009
[TBL] [Abstract][Full Text] [Related]
27. Validated HPLC-MS-MS method for determination of azithromycin in human plasma.
Barrett B; Borek-Dohalský V; Fejt P; Vaingátová S; Huclová J; Nemec B; Jelínek I
Anal Bioanal Chem; 2005 Sep; 383(2):210-7. PubMed ID: 16091946
[TBL] [Abstract][Full Text] [Related]
28. [Influence of roxithromycin combined with fleroxacin on bacterial biofilm induced by Pseudomonas aeruginosa].
Chen Q; Wang R; Fang X
Zhonghua Yi Xue Za Zhi; 1999 Oct; 79(10):757-60. PubMed ID: 11715522
[TBL] [Abstract][Full Text] [Related]
29. Microbiological assay for the determination of azithromycin in ophthalmic solutions.
Salgado HR; Roncari AF
Yao Xue Xue Bao; 2005 Jun; 40(6):544-9. PubMed ID: 16144322
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations.
Emami J; Ghassami N; Ahmadi F
J Pharm Biomed Anal; 2006 Mar; 40(4):999-1005. PubMed ID: 16176866
[TBL] [Abstract][Full Text] [Related]
31. Validation of a fully automated high throughput liquid chromatographic/tandem mass spectrometric method for roxithromycin quantification in human plasma. Application to a bioequivalence study.
Kousoulos C; Tsatsou G; Dotsikas Y; Apostolou C; Loukas YL
Biomed Chromatogr; 2008 May; 22(5):494-501. PubMed ID: 18059078
[TBL] [Abstract][Full Text] [Related]
32. Study on the electrochemical detection of the macrolide antibiotics clarithromycin and roxithromycin in reversed-phase high-performance liquid chromatography.
Pappa-Louisi A; Papageorgiou A; Zitrou A; Sotiropoulos S; Georgarakis E; Zougrou F
J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):57-64. PubMed ID: 11393733
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of agar diffusion bioassay for nisin quantification.
Pongtharangkul T; Demirci A
Appl Microbiol Biotechnol; 2004 Aug; 65(3):268-72. PubMed ID: 14963617
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
Platzer DJ; White BA
J Pharm Biomed Anal; 2006 Apr; 41(1):84-8. PubMed ID: 16298506
[TBL] [Abstract][Full Text] [Related]
35. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro.
Kanai K; Asano K; Hisamitsu T; Suzaki H
Mediators Inflamm; 2004 Dec; 13(5-6):313-9. PubMed ID: 15770046
[TBL] [Abstract][Full Text] [Related]
36. Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.
Shimane T; Asano K; Suzuki M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2001 Dec; 10(6):323-32. PubMed ID: 11817673
[TBL] [Abstract][Full Text] [Related]
37. Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method.
Lecároz C; Campanero MA; Gamazo C; Blanco-Prieto MJ
J Antimicrob Chemother; 2006 Sep; 58(3):557-63. PubMed ID: 16787953
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of roxithromycin on biofilm formation of Pseudomonas aeruginosa.
Ozeki M; Miyamoto N; Hashiba M; Baba S
Acta Otolaryngol Suppl; 1996; 525():61-3. PubMed ID: 8908272
[TBL] [Abstract][Full Text] [Related]
39. [Susceptibility to roxithromycin of gram-positive cocci isolated from patients with lowered immunity].
Mróz E; Podolak-Dawidziak M; Grzybek-Hryncewicz K; Dworniczek E
Med Dosw Mikrobiol; 1994; 46(1-2):5-8. PubMed ID: 7967928
[TBL] [Abstract][Full Text] [Related]
40. Development of a microbiological assay to determine the potency of ceftiofur sodium powder.
Souza MJ; Rolim CM; Melo J; Souza Filho PS; Bergold AM
J AOAC Int; 2007; 90(6):1724-8. PubMed ID: 18193752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
